Loading...

MLTX MOONLAKE IMMUNOTHERAPEUTICS Earnings Reports 8-K Filing

MNLK

MLTX

MOONLAKE IMMUNOTHERAPEUTICS

(MLTX)

2025 8-K

Show Summary

Summary

Financial Statements

Investor Meetings

Financial Results

Financial Results

Investor Presentation

Financial Results Announcement

FDA and EMA Positive Feedba...

Annual General Meeting

Earnings Report

Financial Results Announcement

Regulatory Approval

Financial Results Announcement

Phase 2 Trial Results

Filing with Quantitative Data

Compensation Increases

Financial Results Announcement

Underwriting Agreement and ...

Annual General Meeting

Quantitative Data

Quantitative Data

Financial Results Announcement

External Links:

On May 12, 2025, MoonLake Immunotherapeutics released their financial results for the quarter ending March 31, 2025, detailing their operational performance and financial condition. This filing brings transparency to investors about the company's recent performance.

AI Assistant

MOONLAKE IMMUNOTHERAPEUTICS

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.